Detalhe da pesquisa
1.
Design, synthesis, biological evaluation and molecular docking study of novel pleuromutilin derivatives containing substituted benzoxazole as antibacterial agents.
J Enzyme Inhib Med Chem
; 38(1): 2251712, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37664987
2.
Design, synthesis, and biological evaluation of pleuromutilin derivatives containing 1,2,4-triazole linker.
Drug Dev Res
; 84(4): 703-717, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36896715
3.
Design, synthesis, and biological evaluation of novel pleuromutilin derivatives containing benzimidazoles as effective anti-MRSA agents.
Drug Dev Res
; 84(7): 1437-1452, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534779
4.
Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups.
J Enzyme Inhib Med Chem
; 37(1): 2078-2091, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35875944
5.
Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker.
Bioorg Chem
; 112: 104956, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33991838
6.
Diclofenac and eugenol hybrid with enhanced anti-inflammatory activity through activating HO-1 and inhibiting NF-κB pathway in vitro and in vivo.
Eur J Med Chem
; 259: 115669, 2023 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37517204